Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues

Laboratory Investigation

Volumn 78, Issue 12, 1998, Pages 1591-1606

  Ling, Xia ^a   Sakashita, Naomi ^a   Takeya, Motohiro ^a   Nagai, Ryoji ^a   Horiuchi, Seikoh ^a   Takahashi, Kiyoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CEROID; LIPOFUSCIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ADULT; AGED; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOPSY; BIOPSY; BLOOD CELLS; EPITHELIAL CELLS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NEURONS; ORGAN SPECIFICITY; SUBCELLULAR FRACTIONS;

EID: 0032407736     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. ∈-(carboxymethyl)lysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889-4894.
2. Araki N, Higashi T, Mori T, Shibayama R, Kawabe Y, Kodama T, Takahashi K, Shichiri M, and Horiuchi S (1995). Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur J Biochem 230:408-415.
3. Araki N, Ueno N, Chakrabarti B, Morino Y, and Horiuchi S (1992). Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214.
4. Bao Q and Hughes RC (1995). Galectin-3 expression and effects on cyst enlargement and tubulogenesis in kidney epithelial MDCK cells cultured in three-dimensional matrices in vitro. J Cell Sci 108:2791-2800.
5. Barondes SH, Castronovo V, Cooper DNW, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu FT, Lotan R, Mercuric AM, Monsigny M, Pillai S, Poirer F, Raz A, Rigby PWJ, Rini JM, and Wang JL (1994). Galectins: A family of animal β-galactoside-binding lectins. Cell 76:597-598.
6. Berg TJ, Dahl-Jorgensen K, Torjesen PA, and Hanssen KF (1997). Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM. Diabetes Care 20:1006-1008.
7. Brett J, Schmidt AM, Tan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A, Migheli A, and Stern D (1993). Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143:1699-1712.
8. Bucala R, Makita Z, Koschinsky T, Cerami A, and Vlassara H (1993). Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438.
9. Castellani R, Smith MA, Richey PL, and Perry G (1996). Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 737:195-200.
10. Chang JC, Ulrich PC, Bucala R, and Cerami A (1985). Detection of an advanced glycosylation product bound to protein in situ. J Biol Chem 260:7970-7974.
11. Cherayil BJ, Weiner SJ, and Pillai S (1989). The Mac-2 antigen is a galactose-specific lectin that binds IgE. J Exp Med 170:1959-1972.
12. Craig SS, Krishnaswamy P, Irani AM, Kepley CL, Liu FT, and Schwartz LB (1995). Immunoelectron microscopic localization of galectin-3, an IgE binding protein, in human mast cells and basophils. Anat Rec 242:211-219.
13. Dickson DW, Sinicropi S, Yen SH, Ko LW, Mattiace LA, Bucala R, and Vlassara H (1996). Glycation and microglial reaction in lesions of Alzheimer's disease. Neurobiol Aging 17:733-743.
14. Frigeri LG, Zuberi RI, and Liu FT (1993). ∈BP, a β-galactoside-binding animal lectin, recognizes IgE receptor (Fc∈RI) and activates mast cells. Biochemistry 32:7644-7649.
15. Harman D (1990). Lipofuscin and ceroid formation: The cellular recycling system. In: Porta EA, editor: Lipofuscin and ceroid. New York: Plenum Press, 3-15.
16. Hayase F, Nagaraj RH, Miyata S, Njoroge FG, and Monnier VM (1989). Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem 264:3758-3764.
17. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, Morser J, Stern D, and Schmidt M (1995). The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and coexpression of RAGE and amphoterin in the developing nervous system. J Biol Chem 270:25752-25761.
18. Horie K, Miyata T, Yasuda T, Takeda A, Yasuda Y, Maeda K, Sobue G, and Kurokawa K (1997). Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem Biophys Res Commun 236:327-332.
19. Horiuchi S, Araki N, and Morino Y (1991). Immunochemical approach to characterize advanced glycation end products of the Maillard reaction: Evidence for the presence of a common structure. J Biol Chem 266:7329-7332.
20. Horiuchi S, Araki N, Nakamura K, Ikeda K, Fukunaga Y, and lenaga K (1996). A new fluorescent crosslinker (AGE-X1) isolated from AGE-lysine derivatives. Diabetes 45(Suppl 2): 186A.
21. ∈-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35:8075-8083.
22. Ikeda K, Nagai R, Sakamoto T, Sano H, Araki T, Sakata N, Nakayama H, Yoshida M, Ueda S, and Horiuchi S (1998). Immunochemical approaches to AGE-structures: Characterization of anti-AGE antibodies. J Immunol Methods 215:95-104.
23. Ishii Y, Takami T, Yuasa H, Takei T, and Kikuchi K (1984). Two distinct antigen systems in human B lymphocytes: Identification of cell surface and intracellular antigens using monoclonal antibodies. Clin Exp Immunol 58:183-192.
24. Isobe Y, Chen ST, Nakane PK, and Brown WR (1977). Studies on translocation of immunoglobulins across interstitial epithelium: I - Improvements in the peroxidase-labeled antibody method for application to study of human interstitial mucosa. Acta Histochem Cytochem 10:161-171.
25. Jobst K and Lakatos A (1996). The liver cell histones of diabetic patients contain glycation endproducts (AGEs) which may be lipofuscin components. Clin Chim Acta 256: 203-204.
26. Kimura T, Ikeda K, Takamatsu J, Miyata T, Sobue G, Miyakawa T, and Horiuchi S (1996a). Identification of advanced glycation end products of the Maillard reaction in Pick's disease. Neurosci Lett 219:95-98.
27. Kimura T, Takamatsu J, Ikeda K, Kondo A, Miyakawa T, and Horiuchi S (1996b). Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci Lett 208:53-56.
28. Kodama T, Freeman M, Rohrer L, Zabrewcky J, Matsudaira P, and Krieger M (1990). Type I macrophage scavenger receptor contains a-helical and collagen-like coiled coils. Nature 343:531-535.
29. Kodama T, Reddy, Kishimoto PC, and Krieger M (1988). Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc Natl Acad Sci USA 85: 9238-9242.
30. Koths K, Taylor E, Halenbeck R, Casipit C, and Wang A (1993). Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem 268:14245-14249.
31. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, and Takahashi K (1995). Immunonistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147:654-667.
32. Li YM, Mitsuhashi T, Wojciechowicz D, Shimizu N, Li J, Stitt A, He C, Banerjee D, and Vlassara H (1996). Molecular identity and cellular distribution of advanced glycation end-product receptors: Relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci USA 93: 11047-11052.
33. Li YM, Tan AX, and Vlassara H (1995). Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nat Med 1:1057-1061.
34. Liu FT, Hsu DK, Zuberi RI, Hill PN, Shenhav A, Kuwabara I, and Chen SS (1996). Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. Biochemistry 35:6073-6079.
35. Maeda R (1967). The origin and characteristics of ceroid. Acta Pathol Jpn 17:439-456.
36. Maeda R, Takada R, Hagihara T, and Yamagata I (1965). Leucomalachite green staining for ceroid. Proc Jpn Histochem Assoc 6th Annual General Meeting. Kyoto: Japan Society of Histochemistry and Cytochemistry, 25.
37. Maillard LC (1912). Action des acides amines sur les sucres: Formation des melanoidines par voie methodique. C R Acad Sci (Paris) 154:66-68.
38. Mason DY and Sammons R (1978). Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol 31:454-460.
39. Mitchinson MJ, Hothersall DC, Brooks PN, and Burbure CD (1985). The distribution of ceroid in human atherosclerosis. J Pathol 145:177-183.
40. Miyata S and Monnier V (1992). Immunohistochemical detection of advanced glycation end products in diabetic tissues using monoclonal antibody to pyrraline. J Clin Invest 89: 1102-1112.
41. ∈-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. J Invest Dermatol 108:797-802.
42. Mori T, Takahashi K, Higashi T, Takeya M, Kume S, Kawabe Y, Kodama T, and Horiuchi S (1995). Localization of advanced glycation end products of Maillard reaction in bovine tissue and their endocytosis by macrophage scavenger receptors. Exp Mol Pathol 63:135-152.
43. Naito M, Suzuki H, Mori T, Matsumoto A, Kodama T, and Takahashi K (1992). Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 141:591-599.
44. Nakamura K, Hasegawa T, Fukunaga Y, and lenaga K (1992). Cross-lines A and B as candidates for the fluorophores in age-and diabetes-related cross-linked proteins, and their diacetates predicted by Maillard reaction of α-N-acetyl-L-lysine with D-glucose. J Chem Soc Chem Commun 14:992-994.
45. Nakamura K, Nakazawa Y, and lenaga K (1997). Acid-stable fluorescent advanced glycation end products: Vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 232:227-230.
46. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, Dohi K, Makita Z, Vlassara H, and Bucala R (1993). Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 143:1649-1656.
47. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YCE, Elliston K, Stern D, and Shaw A (1992). Cloning and expression of a cell surface receptor for advanced glycosylation endproducts of proteins. J Biol Chem 267:14998-15004.
48. Newman I and Wikinson PC (1992). Methods for phenotyping polarized and locomotor human lymphocytes. J Immunol Methods 147:43-50.
49. Niwa T, Katsuzaki T, Ishizaki Y, Hayase F, Miyazaki T, Uematsu T, Tatemichi N, and Takei Y (1997a). Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes. FEBS Lett 407:297-302.
50. Niwa T, Katsuzaki T, Miyazaki S, Miyazaki T, Ishizaki Y, Hayase F, Tatemichi N, and Takei Y (1997b). Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest 99:1272-1280.
51. Niwa T, Miyazaki S, Katsuzaki T, Tatemichi N, Takei Y, Miyazaki T, Morita T, and Hirasawa Y (1995). Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. Kidney Int 48:771-778.
52. ∈-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 50:1303-1309.
53. Pearse AGE (1985a). Pigments and pigment precursors. In: Pearse AGE, editor: Histochemistry. Edinburgh: Churchill Livingstone, 874-928.
54. Pearse AGE (1985b). Lipids, lipoproteins and proteolipids. In: Pearse AGE, editor: Histochemistry. Edinburgh: Churchill Livingstone, 833.
55. Porta EA, Mower HF, Moroye M, Lee C, and Palumbo NE (1988). Differential features between lipofuscin (age pigment) and various experimentally produced "ceroid pigments". In: Zs.-Nagy I, editor: Lipofuscin-1987: State of the art: Proceedings of an international symposium held in Debrecen, Hungary, on 26-30 August, 1987. Amsterdam: Science Publishers, 341-374.
56. Sakai H, Jinde K, Suzuki D, Yagame M, and Nomoto Y (1996). Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy. Transplantation 11 (Suppl 5):66-71.
57. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Wang F, Pan YUE, Tsang TC, and Stern D (1992). Isolation and characterization of two binding proteins for advanced glycosylation endproducts from bovine lung which are present on the endothelial cell surface. J Biol Chem 256:14987-14997.
58. Schmidt AM, Weidman E, Lalla E, Yan SD, Hori O, Cao R, Brett JG, and Lamster IB (1996). Advanced glycation end-products (AGEs) induce oxidant stress in the gingiva: A potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodont Res 31:508-515.
59. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, and Stern D (1993). Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 91:2155-2168.
60. Sell DR and Monnier VM (1989). Structure elucidation of a senescence cross-link from human extracellular matrix: Implication of pentoses in the aging process. J Biol Chem 264:21597-21602.
61. Smith SH, Brown MH, Rowe D, Carllard RE, Beverley PCL (1986). Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL-1. Immunology 58:63-70.
62. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiuchi S, Takahashi K, Kruijt JK, van Berkel TJC, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, and Kodama T (1997). A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386:292-296.
63. Takedo A, Yasuda T, Miyata T, Mizuno K, Li M, Yoneyama S, Horie K, Maeda K, and Sobue G (1996). Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neurosci Lett 221:17-20.
64. Tao Q, Srivastava G, Loke SL, Chan EYT, and Ho FCS (1994). Improved double immunohistochemical staining method for cryostat and paraffin wax sections, combining alkaline phosphatase anti-alkaline phosphatase and indirect immunofluorescence. J Clin Pathol 47:597-600.
65. van den Brule FA, Fernandez PL, Buicu C, Liu FT, Jackers P, Lambotte R, and Castronovo V (1997). Differential expression of galectin-1 and galectin-3 during first trimester human embryogenesis. Dev Dyn 209:399-405.
66. Varndell IM, Tapia FJ, Mey JD, Rush RA, Bloom SR, and Polak JM (1982). Electron immunocytochemical localization of enkephalin-like material in catecholamine-containing cells of the carotid body, the adrenal medulla, and in pheochromocytomas of man and other mammals. J Histochem Cytochem 30:682-690.
67. Vlassara H, Bucala R, and Striker L (1994). Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70: 138-151.
68. Vlassara H, Li YM, Imani F, Wojciechowicz D, Yang Z, Liu FT, and Cerami A (1995). Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): A new member of the AGE-receptor complex. Mol Med 1:634-646.
69. Wang L, Inohara H, Pienta KJ, and Raz A (1995). Galectin-3 is a nuclear matrix protein which binds RNA. Biochem Biophys Res Commun 217:292-303.
70. Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpal P, Suthanthiran M, and Vlassara H (1991). Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: Relationship to macrophage receptor for glucose-modified proteins. J Exp Med 174:515-524.
71. Yin D (1995). Studies on age pigments evolving into a new theory of biological aging. Gerontology 41(Suppl)2:159-172.
72. Yin D (1996). Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med 21:871-888.